ChiCTR2400086629 版本V1.0 版本创建时间2024/07/08 10:47:01 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400086629 

最近更新日期:

Date of Last Refreshed on:

2024-07-08 10:46:44 

注册时间:

Date of Registration:

2024-07-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

山楂喷雾剂对维持性血液透析患者口渴症的应用效果研究

Public title:

Study on the application effect of hawthorn spray on thirst in maintenance hemodialysis patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

山楂喷雾剂对维持性血液透析患者口渴症的应用效果研究

Scientific title:

Study on the application effect of hawthorn spray on thirst in maintenance hemodialysis patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

穆泓 

研究负责人:

穆泓 

Applicant:

Mu hong 

Study leader:

Mu hong 

申请注册联系人电话:

Applicant telephone:

+86 156 8720 7011

研究负责人电话:

Study leader's
telephone:

+86 156 8720 7011

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15687207011@139.com

研究负责人电子邮件:

Study leader's E-mail:

15687207011@139.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

云南省玉溪市红塔区聂耳路21号

研究负责人通讯地址:

云南省玉溪市红塔区聂耳路21号

Applicant address:

No.21 Nie 'er Road, Hongta District, Yuxi City, Yunnan Province

Study leader's address:

No.21 Nie 'er Road, Hongta District, Yuxi City, Yunnan Province

申请注册联系人邮政编码:

Applicant postcode:

653100

研究负责人邮政编码:

Study leader's postcode:

653100

申请人所在单位:

玉溪市人民医院

Applicant's institution:

Yuxi People 's Hospital

研究负责人所在单位:

玉溪市人民医院

Affiliation of the Leader:

Yuxi People 's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023kmykdx6f114

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

昆明医科大学第六附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Sixth Affiliated Hospital of Kunming Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-11-28 00:00:00

伦理委员会联系人:

张文海

Contact Name of the ethic committee:

Zhang wenhai

伦理委员会联系地址:

云南省玉溪市红塔区聂耳路21号

Contact Address of the ethic committee:

No.21 Nie 'er Road, Hongta District, Yuxi City, Yunnan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 198 6902 7289

伦理委员会联系人邮箱:

Contact email of the ethic committee:

19869027289@139.com

研究实施负责(组长)单位:

玉溪市人民医院

Primary sponsor:

Yuxi People 's Hospital

研究实施负责(组长)单位地址:

云南省玉溪市红塔区聂耳路21号

Primary sponsor's address:

No.21 Nie 'er Road, Hongta District, Yuxi City, Yunnan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

云南省

市(区县):

Country:

China

Province:

Yunnan province

City:

单位(医院):

玉溪市人民医院

具体地址:

云南省玉溪市红塔区聂耳路21号

Institution
hospital:

Yuxi People 's Hospital

Address:

No.21 Nie 'er Road, Hongta District, Yuxi City, Yunnan Province

经费或物资来源:

自筹资金

Source(s) of funding:

self-finance

研究疾病:

维持性血液透析患者  

Target disease:

maintenance hemodialysis patients

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

制定完善的山楂喷雾剂干预方案,验证其对MHD口渴患者口渴程度、唾液分泌量、透析间期体重增长的临床疗效,为MHD患者的治疗和护理做一些新的探索和尝试。  

Objectives of Study:

To develop a perfect Hawthorn Spray intervention program to verify its clinical efficacy on thirst, saliva secretion and weight gain during dialysis in MHD patients with thirst, and to make some new explorations and attempts for the treatment and nursing of MHD patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄>18岁; 2.长期定期血液透析治疗的患者; 3.口渴程度数字评分>3分; 4.意识清楚、病情稳定、能够交流的患者; 5.知情同意并自愿接受干预。

Inclusion criteria

1.age > 18 years old ; 2.patients with long-term regular hemodialysis treatment ; 3.digital score of thirst degree > 3 points ; 4.patients with clear consciousness, stable condition and communication ability ; 5.Informed consent and voluntary intervention.

排除标准:

1.不能耐受山楂的患者; 2.既往史有口腔干燥症的患者; 3.糖尿病患者。

Exclusion criteria:

1.patients who could not tolerate hawthorn ; 2.patients with previous history of oral dryness ; 3.patients with diabetes.

研究实施时间:

Study execute time:

From 2024-07-15 00:00:00 To 2024-10-15 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-07-15 00:00:00 To 2024-10-15 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

40

Group:

control group

Sample size:

干预措施:

常规健康宣教

干预措施代码:

Intervention:

Routine health education

Intervention code:

组别:

干预组

样本量:

40

Group:

interventional group

Sample size:

干预措施:

山楂喷雾剂+常规健康宣教

干预措施代码:

Intervention:

Hawthorn spray + routine health education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

云南省 

市(区县):

 

Country:

China

Province:

Yunnan province

City:

单位(医院):

玉溪市人民医院 

单位级别:

三甲 

Institution
hospital:

Yuxi People 's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

口渴程度评分表

指标类型:

主要指标

Outcome:

Thirst Rating Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

超滤量

指标类型:

次要指标

Outcome:

ultrafiltration volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

唾液

组织:

Sample Name:

Saliva

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-07-08 10:46:44